NCT03208309View on ClinicalTrials.gov

Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

December 31, 2015

Conditions
Complications of Diabetes MellitusDiabetes MellitusDiabetes Mellitus, Type 2
Interventions
DRUG

Diacerein

DRUG

Placebo

Trial Locations (3)

Unknown

Centro de Estudos em Diabetes e Hipertensão, Fortaleza

Universidade Estadual de Feira de Santana, Feira de Santana

Universidade Estadual de Campinas, Campinas

Sponsors

Lead Sponsor

ANS Pharma
All Listed Sponsors
collaborator

University of Campinas, Brazil

OTHER

collaborator

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

lead

ANS Pharma

INDUSTRY

NCT03208309 - Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin | Biotech Hunter | Biotech Hunter